InVivoMAb anti-mouse B220
BE0067
ApplicationsOther Application
Product group Antibodies
Overview
- SupplierBio X Cell
- Product NameInVivoMAb anti-mouse B220
- Delivery Days Customer7
- ApplicationsOther Application
- CertificationResearch Use Only
- ClonalityMonoclonal
- Clone IDRA3.3A1/6.1 (TIB-146)
- Concentration4-11 mg/ml
- Estimated Purity>95%
- IsotypeIgM
- Storage Instruction2°C to 8°C
- UNSPSC12352203
References
- Bouffi C, Kartashov AV, Schollaert KL, et al. Transcription Factor Repertoire of Homeostatic Eosinophilopoiesis. J Immunol. 2015,195(6):2683-95. doi: 10.4049/jimmunol.1500510Read this paper
- Carmi Y, Spitzer MH, Linde IL, et al. Allogeneic IgG combined with dendritic cell stimuli induce antitumour T-cell immunity. Nature. 2015,521(7550):99-104. doi: 10.1038/nature14424Read this paper
- Becher B, Schlitzer A, Chen J, et al. High-dimensional analysis of the murine myeloid cell system. Nat Immunol. 2014,15(12):1181-9. doi: 10.1038/ni.3006Read this paper
- Smyth LA, Ratnasothy K, Moreau A, et al. Tolerogenic Donor-Derived Dendritic Cells Risk Sensitization In Vivo owing to Processing and Presentation by Recipient APCs. J Immunol. 2013,190(9):4848-60. doi: 10.4049/jimmunol.1200870Read this paper
- Alam S, Sant AJ. Infection with seasonal influenza virus elicits CD4 T cells specific for genetically conserved epitopes that can be rapidly mobilized for protective immunity to pandemic H1N1 influenza virus. J Virol. 2011,85(24):13310-21. doi: 10.1128/JVI.05728-11Read this paper
- Olkhanud PB, Damdinsuren B, Bodogai M, et al. Tumor-evoked regulatory B cells promote breast cancer metastasis by converting resting CD4⁺ T cells to T-regulatory cells. Cancer Res. 2011,71(10):3505-15. doi: 10.1158/0008-5472.CAN-10-4316Read this paper